Search

Search Results

• 

  Influenza vaccination is safe and effective in patients suffering from fibromyalgia syndrome

  J. N. Ablin, V. Aloush, A. Brill, M. Berman, M. Barzilai, D. Caspi, M. Mandelboim, D. Levartovsky, A. Polachek, Y. Wolman, D. Paran, M. Barkagan, O. Elkayam

  57-61

  16-09-2015

  https://doi.org/10.4081/reumatismo.2015.823

  2189

  PDF: 1052
• 

  Adherence to vaccination against SARS-CoV-2 and vaccine safety in patients with IgG4-related disease

  Linda Mastromanno, Federico Giardina, Angelica Gattamelata, Serena Colafrancesco, Simona Truglia, Francesca Romana Spinelli, Edoardo Simoncelli, Bruno Lucchino, Fabrizio Conti, Roberta Priori

  22-01-2025

  https://doi.org/10.4081/reumatismo.2025.1744

  1246

  PDF: 77

  SUPPLEMENTARY MATERIAL: 30
• 

  Idiopathic inflammatory myopathies linked to vaccination against SARS-CoV-2: a systematic review

  A. Camargo-Coronel, H. Quiñones-Moya; M.R. Hernández-Zavala; J.R. Hernández-Vázquez, M.Á. Vázquez-Zaragoza

  08-05-2023

  https://doi.org/10.4081/reumatismo.2023.1548

  1956

  PDF: 1310
• 

  Disseminated cutaneous herpes simplex infection after COVID-19 vaccination in a rheumatoid arthritis patient: a case report and review

  D. Mohamadzadeh, S. Assar, M. Pournazari, P. Soufivand, S. Danaei

  13-09-2022

  https://doi.org/10.4081/reumatismo.2022.1489

  1722

  PDF: 936
• 

  Vaccination of mice for research purpose: alum is as effective as and safer than complete Freund adjuvant

  N. Bassi, R. Luisetto, A. Ghirardello, M. Gatto, B. Bottazzi, Y. Shoenfeld, L. Punzi, A. Doria

  380-387

  20-12-2012

  https://doi.org/10.4081/reumatismo.2012.380

  2354

  PDF: 984
• 

  Erythema nodosum after COVID-19 vaccine

  B. Maranini, G. Ciancio, M. Corazza, F. Ruffilli, G. Galoppini, M. Govoni

  03-05-2022

  https://doi.org/10.4081/reumatismo.2022.1475

  2675

  PDF: 1046
• 

  Myositis after SARS-CoV-2 vaccination occurs more frequently than assumed and is probably causally related

  J. Finsterer, A.S. MohanaSundaram, F. Scorza

  18-09-2023

  https://doi.org/10.4081/reumatismo.2023.1601

  1246

  PDF: 436
• 

  Response to: myositis after SARS-CoV-2 vaccination occurs more frequently than assumed and is probably causally related

  H. Quiñones-Moya, A. Camargo-Coronel, M.R. Hernández-Zavala

  18-09-2023

  https://doi.org/10.4081/reumatismo.2023.1623

  909

  PDF: 303
• 

  Comment to: Disseminated cutaneous herpes simplex, COVID-19 vaccination and rheumatoid arthritis patient: a case report and review

  B. Joob, V. Wiwanitkit

  29-12-2022

  https://doi.org/10.4081/reumatismo.2022.1527

  770

  PDF: 334
• 

  Patients with systemic lupus erythematosus and their experience with vaccination against COVID-19: a descriptive and explanatory study

  F. Ceccarelli, V. Covelli, G. Olivieri, F. Natalucci, C. Alessandri, F. Conti

  13-09-2022

  https://doi.org/10.4081/reumatismo.2022.1491

  1123

  PDF: 547
• 

  Herpes zoster seven days after SARS-CoV-2 vaccination in a patient with ankylosing spondylitis under adalimumab

  J. Finsterer

  03-05-2022

  https://doi.org/10.4081/reumatismo.2022.1474

  1969

  PDF: 519
• 

  Reply to: “Herpes zoster seven days after SARS-CoV-2 vaccination in a patient with ankylosing spondylitis under adalimumab” by Josef Finsterer

  B. Maranini, G. Ciancio, R. Cultrera, M. Govoni

  03-05-2022

  https://doi.org/10.4081/reumatismo.2022.1482

  2207

  PDF: 598